PDCD1 and adult T-cell leukemia/lymphoma: The potential correlation between treatment with PD‐1 inhibitors and clinical staging of ATLL is a subject of investigation, and the association of PD‐1 blockade therapy with MHC class II expression in ATLL remains a topic of debate.